{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.900 vs. cons $0.894",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "MISS",
      "answer": "pred ~3.10% vs. cons 3.25%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.498B vs. cons $1.503B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 2026 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$0.920 vs. cons $0.932",
      "confidence": "LOW"
    },
    {
      "kpi": "FY 2026 organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide 3%-4% vs. cons 3.77%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 adjusted EPS growth",
      "prediction": "UNCHANGED",
      "answer": "guide 5%-8% vs. cons $3.753",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 Q3 de-risking should drive estimate pressure",
  "day5_confidence": "LOW"
}